Skip to content
POM-V Prescription Required Companion Animal

Methadyne 10 mg/ml Solution for Injection for Dogs and Cats

Active ingredient: Methadone Hydrochloride

Form

Injection

Species

Cats Dogs

Manufacturer

Zoetis UK Limited

VMD MA No.

42058/5224

What it's used for

• • a neuroleptic drug.

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Methadone Hydrochloride

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Methadyne 10 mg/ml Solution for Injection for Dogs and Cats — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 26 Mar 2026.

•
•
a neuroleptic drug.
Before administration the body weight should be accurately determined.
Analgesia
Dogs: 0.5 to 1 mg Methadone HCl per kg bodyweight, SC, IM or IV
(corresponding to 0.05 to 0.1 ml/kg)
Cats: 0.3 to 0.6 mg Methadone HCl per kg bodyweight, IM
(corresponding to 0.03 to 0.06 ml/kg)
To ensure accuracy of dosing in cats, an appropriately calibrated syringe should be
used to administer the product.
As the individual response to methadone is variable, and depends partly on the
dosage, the age of the patient, individual differences in pain sensitivity and general
condition, the optimal dosing regimen should be individually based.
In dogs, onset of action is 1 hour following subcutaneous administration,
approximately 15 minutes following intramuscular injection and within 10 minutes
following intravenous injection. Duration of effect is approximately 4 hours following
intramuscular or intravenous administration.
In cats, following intramuscular injection, onset of action is 15 minutes, and the
duration of effect is 4 hours on average.

Revised: December 2025
MA split from NI Expiry following AN: 02972/2025Page 4 of 7
The animal should be examined regularly to assess if additional analgesia is
subsequently required.
Premedication and/or neuroleptanalgesia
Dogs:
• Methadone HCl 0.5-1 mg/kg bodyweight, IV, SC or IM
(corresponding to 0.05 to 0.1 ml/kg)
Combinations e.g.:
• Methadone HCl 0.5 mg/kg bodyweight, IV (corresponding to 0.05 ml/kg), + e.g.
midazolam or diazepam
Induction with propofol, maintenance with isoflurane in oxygen.
• Methadone HCl 0.5 mg/kg bodyweight, IV (corresponding to 0.05 ml/kg), + e.g.
acepromazine
Induction with thiopentone or propofol to effect, maintenance with isoflurane in
oxygen or induction with diazepam and ketamine.
• Methadone HCl 0.5 -1.0 mg/kg bodyweight, IV or IM (corresponding to 0.05 to
0.1 ml/kg), + α2-agonist (e.g. xylazine or medetomidine)
Induction with propofol, maintenance with isoflurane in oxygen, in combination
with fentanyl or total intravenous anaesthesia (TIVA) protocol: maintenance with
propofol in combination with fentanyl.
TIVA protocol: induction propofol, to effect. Maintenance with propofol and
remifentanil.
Chemical-physical compatibility has only been demonstrated for dilutions 1:5 with the
following solutions for infusion: sodium chloride 0.9%, Ringer’s solution, and glucose
5%.
Cats:
• Methadone HCl 0.3-0.6 mg/kg bodyweight, IM (corresponding to 0.03 to
0.06 ml/kg)
▪
(e.g.ketamine).
▪
(e.g.
▪
Doses are dependent on the desired degree of analgesia and sedation, desired
duration of effect and the concurrent use of other analgesics and anaesthetics.
When used in combination with other products, lower dosages can be used.
For safe use with other veterinary medicinal products, reference must be made to the
relevant product literature.
Do not use in known cases of hypersensitivity to the active substance or to any of the
excipients.
Do not use in animals with advanced respiratory failure.
Do not use in animals with severe liver and renal dysfunction.
In very common cases (more than 1 in 10 animals displaying adverse reaction(s)
during the course of one treatment), the following reactions have been observed after
administration of the product:
Cats: Respiratory depression may be seen. Mild excitatory reactions have been
observed: lip licking, vocalisation, urination, defaecation, mydriasis, hyperthermia and
diarrhoea. Hyperalgesia has been reported. All reactions were transient.
Dogs: Respiratory depression and bradycardia may be seen. Mild reactions have
been observed: panting, lip licking, salivation, vocalisation, irregular breathing,
hypothermia, fixed stare and body tremors. Occasional urination and defaecation can
be seen within the first hour post dose. All reactions were transient.
Due to the variable individual response to methadone, animals should be monitored
regularly to ensure sufficient efficacy for the desired duration of effect.
Use of the product must be preceded by a thorough clinical examination.

Revised: December 2025
MA split from NI Expiry following AN: 02972/2025Page 2 of 7
In cats, pupil dilation is seen long after the analgesic effect has disappeared. It is
therefore not an adequate parameter to assess clinical efficacy of the administered
dose.
Greyhounds may require higher doses than other breeds to achieve efficacious
plasma levels.

Special precautions for use in animals
Methadone may occasionally cause respiratory depression and, as with other opioid
drugs, care should be taken when treating animals with impaired respiratory function,
or animals that are receiving drugs that can cause respiratory depression. To ensure
safe use of the product, treated animals should be monitored regularly, including
examination of heart rate and respiratory rate.
As methadone is metabolised by the liver, its intensity and duration of action may be
affected in animals with impaired liver function.
In case of renal, cardiac or hepatic dysfunction, or shock, there may be greater risk
associated with the use of the product.
The safety of methadone has not been demonstrated in dogs less than 8 weeks and
cats less than 5 months of age.
The effect of an opioid on head injury is dependent on the type and severity of the
injury and the respiratory support supplied.
Safety has not been fully evaluated in clinically compromised cats.
Due to the risk of excitation, repeated administration in cats should be used with
care.
The benefit/risk ratio for using the product should be made by the attending
veterinarian.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
Methadone can cause respiratory depression following spillage onto the skin or
accidental self-injection. Avoid skin, eye and mouth contact, and wear impermeable
gloves when handling the product. In cases of spillage onto the skin, or splashing into
the eyes, wash immediately with large amounts of water. Remove contaminated
clothes.
People with known hypersensitivity to methadone should avoid contact with the
veterinary medicinal product. Methadone has the potential to cause stillbirths.
Pregnant women are advised not to handle the product.
In the case of accidental self-injection, seek medical advice immediately and show
the package leaflet to the physician but DO NOT DRIVE as sedation may occur.
ADVICE TO DOCTORS: Methadone is an opioid whose toxicity may cause clinical
effects including respiratory depression or apnoea, sedation, hypotension and coma.
When respiratory depression occurs controlled ventilation should be installed.
Administration of the opioid antagonist naloxone to reverse the symptoms is
recommended.
Other precautions
None

Revised: December 2025
MA split from NI Expiry following AN: 02972/2025Page 3 of 7
For concurrent use with neuroleptics refer to section 4.9.
Methadone can potentiate the effects of analgesics, central nervous system inhibitors
and substances that cause respiratory depression. Concomitant or subsequent use
of the veterinary medicinal product with buprenorphine may lead to lack of efficacy.
Store below 30ºC.

Revised: December 2025
MA split from NI Expiry following AN: 02972/2025Page 7 of 7
Not applicable.
5.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.